Cargando…
Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
Remyelination therapies, which are currently under development, have a great potential to delay, prevent or even reverse disability in multiple sclerosis patients. Several models are available to study the effectiveness of novel compounds in vivo, among which is the cuprizone model. This model is ch...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783537/ https://www.ncbi.nlm.nih.gov/pubmed/36555733 http://dx.doi.org/10.3390/ijms232416093 |